{"id":9091,"date":"2024-03-08T18:38:27","date_gmt":"2024-03-08T10:38:27","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9091"},"modified":"2024-03-19T11:38:53","modified_gmt":"2024-03-19T03:38:53","slug":"the-board-of-directors-release-the-prohibition-on-managers-from-participation-in-competition-businesses-4","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-release-the-prohibition-on-managers-from-participation-in-competition-businesses-4\/","title":{"rendered":"The Board of Directors release the prohibition on managers from participation in competition businesses."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a04<\/td>\nDate of announcement<\/td>\n2024\/03\/08<\/td>\nTime of announcement<\/td>\n18:38:20<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors release the prohibition on\r\nmanagers from participation in competition businesses.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2024\/03\/08<\/td>\nTo which item it meets<\/td>\nparagraph 21<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of the board of directors resolution:\r\n  2024\/03\/08\r\n2.Name and title of the managerial officer with\r\n  permission to engage in competitive conduct:\r\n  Chang Ming-Cheng,General Manager.\r\n  Chou Cheng-Hsiao,CFO.\r\n3.Items of competitive conduct in which the \r\n  officer is permitted to engage:\r\n  Acting in the business of the same or similar \r\n  nature of a company as that of the company.\r\n4.Period of permission to engage in the \r\n  competitive conduct:\r\n  For the duration of being employed as a manager \r\n  of the Company.\r\n5.Circumstances of the resolution (please describe \r\n  the results of voting in accordance with Article \r\n  32 of the Company Act):\r\n  All directors present at the meeting pass \r\n  unanimously.\r\n6.If the permitted competitive conduct belongs to \r\n  the operator of a mainland China area enterprise,\r\n  the name and title of the managerial officer (if\r\n  it is not the operator of a mainland China area\r\n  enterprise, please enter \u201cN\/A\u201d below):N\/A\r\n7.Company name of the mainland China area enterprise\r\n  and the officer's position in the enterprise:\r\n  N\/A\r\n8.Address of the mainland China area enterprise:\r\n  N\/A\r\n9.Operations of the mainland China area enterprise:\r\n  N\/A\r\n10.Impact on the company's finance and business:\r\n   None\r\n11.If the managerial officer has invested in the \r\n   mainland China area enterprise, the monetary \r\n   amount of the investment and the officer's\r\n   shareholding ratio:N\/A\r\n12.Any other matters that need to be specified:\r\n   None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a04 Date of announcement 2024\/03\/08 Time of announcement 18:38:20 Subject The Board of Directors release the prohibition on managers from participation in competition businesses. Date of events 2024\/03\/08 To which item it meets paragraph 21 Statement 1.Date of the board of directors resolution: 2024\/03\/08 2.Name and title of the managerial officer with permission …<\/p>\n
  The Board of Directors release the prohibition on managers from participation in competition businesses.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-9091","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9091"}],"version-history":[{"count":1,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9091\/revisions"}],"predecessor-version":[{"id":9092,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9091\/revisions\/9092"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}